UnknownNot Applicable

Lateral Prostate Capsule Sparing Versus Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male

China100 participantsStarted 2021-09-01

Plain-language summary

To compare the perioperative, functional, and oncologic outcomes between nerve sparing and lateral prostate capsule sparing robot-assisted radical cystectomy with orthotopic ileal neobladder in male patients with bladder cancer.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male patients aged 18 or older.
✓. Patients those who are diagnosed with urothelial carcinoma.
✓. Patients those who are without tumour in the bladder neck or urethra, and prostate cancer was ruled out by MRI and serum T-PSA\<2.5ng/ml.
✓. Patients those who are capable of receiving radical cystectomy with orthotopic ileal neobladder.
✓. Patients those who are able to cooperate and complete the follow-up.
✓. Patients those who volunteer to participate in this study and sign the informed consens.

Exclusion criteria

✕. Patients thsoe who are diagnosed distant metastasis before surgery.
✕. Patients those who are diagnosed with other malignancies.
✕. Patients those who had received pelvic radiotherapy or major pelvic operation.

What they're measuring

day-time continence rate

Timeframe: 6 months

night-time continence rate

Timeframe: 6 months

postoperative sexual function

Timeframe: 6 months

Trial details

NCT IDNCT04966949

SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-31

Contact for this trial

Kaiwen Li, MD

+86-15989252628 likw6@mail.sysu.edu.cn

View on ClinicalTrials.gov More Bladder Cancer trials